Literature DB >> 3308083

Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.

P L Triozzi1, P Kenney, D Young, J J Rinehart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308083

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  2 in total

1.  Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer.

Authors:  H O Klein; G Golbach; P Voigt; C Coerper; C Bernhardt
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  A phase II study of recombinant interferon-beta (r-hIFN-beta 1a) in combination with 5-fluorouracil (5-FU) in the treatment of patients with advanced colorectal carcinoma.

Authors:  J K Joffe; T J Perren; C Bradley; J Primrose; S Hallam; U Ward; J M Illingworth; P J Selby
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.